Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mycobacterial energy metabolism encompasses the biochemical pathways and molecular machinery used by Mycobacterium species, including Mycobacterium tuberculosis, to generate, store, and utilize energy. Key pathways include the TCA cycle, glycolysis, pentose phosphate pathway, fatty acid metabolism, and the electron transport chain. The system is highly adaptable, allowing mycobacteria to survive under diverse environmental conditions such as nutrient limitation and hypoxia. Targeting mycobacterial energy metabolism, especially components like ATP synthase or specific ETC complexes, is an attractive strategy for novel anti-tubercular therapies.
Inhibition of ATP synthesis; Disruption of electron transport chain; Targeting metabolic enzymes
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterial Energy Metabolism (N/A).